Archive for December 2023

Chiesi Global Rare Diseases, a Boston-based business unit of Italian biopharma firm Chiesi Group, scored an approval from the U.S. Food and Drug Administration for a skin disorder drug. Plus, other life sciences news you may have missed. Read More

These are the top tech stories of 2023 in Greater Boston. Read More

From Dana-Farber’s split with MGB to the hack of Harvard Pilgrim, here are four of the biggest stories from the Boston-area healthcare sector in 2023. Read More

As airlines shift their strategies in the post-Covid-19 world, here’s how holiday travel is trending in 2023. Read More

Americans under the age of 18 generated $11 billion in advertising revenue during 2022 for Facebook, Instagram, Snapchat, TikTok, X (formerly known as Twitter) and YouTube, according to a new Harvard public health study. Read More

The Boston-based venture capital firm focusing on underrepresented founders is the latest organization to cut staff, joining a staff-trimming trend across many industries that defined 2023. Read More

A 273-unit apartment building in Hyde Park next to the Readville commuter rail station is headed to auction next month. Read More

Mass General Brigham, the state’s largest health system, is reinstating masking requirements as Covid-19 cases in Massachusetts continue to increase. Read More

After a rough 2023, real estate leaders are looking for relief, whether with lower interest rates or policy changes from Beacon Hill and City Hall. Read More

Greater Boston’s real estate sector is in its toughest spot since the Great Recession a decade and a half ago. Here’s how the slowdown has played out in different parts of the industry. Read More